Men with high-risk prostate cancer have a higher likelihood of residual disease after prostatectomy and may require radiation ...

When prostate cancer returns or is at high risk of returning after surgery, radiation to the prostate bed (the area where the prostate used to be) is often recommended. The standa ...

At 8 years, SBRT and radical prostatectomy had similar disease control in the PACE-A trial, with less urinary incontinence ...

Five-year phase 3 results support hypofractionated radiotherapy as a shorter treatment option after prostatectomy but raise concern about late GU toxicity.

Stereotactic body radiation therapy significantly improved quality of life outcomes, including urinary incontinence and ...

Five-treatment stereotactic body radiation therapy (SBRT) provided excellent long-term cancer control with fewer urinary and ...

PACE is the first phase 3 randomized trial directly comparing radical prostatectomy with SBRT in men with low- to intermediate-risk prostate cancer.

Radical prostatectomy does not ensure a cure, with one in three men experiencing cancer recurrence and elevated PSA levels within 10 years post-surgery. Significant side effects of prostate removal ...

For the hundreds of thousands of men who undergo radical prostatectomy each year, one question looms over every postoperative ...

Men with prostate cancer face different long-term risks depending on whether they choose surgery or radiation therapy, with ...

A cohort study found that pre-radical prostatectomy levels greater than 20 ng/mL were associated with increased all-cause mortality risk and prostate cancer-specific mortality risk. Patients with a ...

Medicana Health Group is highlighting the role of robot-assisted surgery in prostate cancer treatment as a 2026 research ...